1. Home
  2. TTRX vs SKYH Comparison

TTRX vs SKYH Comparison

Compare TTRX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.84

Market Cap

285.1M

Sector

Health Care

ML Signal

HOLD

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

HOLD

Current Price

$10.57

Market Cap

327.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
SKYH
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
285.1M
327.2M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
TTRX
SKYH
Price
$9.84
$10.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$8.00
$13.13
AVG Volume (30 Days)
46.1K
189.9K
Earning Date
05-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
105.11
EPS
N/A
N/A
Revenue
N/A
$27,540,000.00
Revenue This Year
N/A
$78.89
Revenue Next Year
N/A
$73.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.57
52 Week Low
$2.57
$8.22
52 Week High
$11.69
$11.70

Technical Indicators

Market Signals
Indicator
TTRX
SKYH
Relative Strength Index (RSI) 58.30 50.07
Support Level $2.81 $10.13
Resistance Level $10.72 $11.17
Average True Range (ATR) 0.62 0.40
MACD -0.05 -0.05
Stochastic Oscillator 55.41 30.84

Price Performance

Historical Comparison
TTRX
SKYH

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.

Share on Social Networks: